title: Theoretical limits of spatial resolution in elliptical-centric contrast-enhanced 3D-MRA.
abstract: The point spread function (PSF) for contrast-enhanced three-dimensional (3D) MR angiography using the elliptical centric view order is derived. This view order has been shown previously to provide high venous suppression thereby enabling long acquisition times capable of high spatial resolution. The dependence of the PSF on TR, field of view (FOV), scan time, and trigger time are shown explicitly. Theoretical predictions are corroborated with experimental results in phantoms and in vivo. The PSF width decreases as the square root of the product of TR and the two phase encoding FOV's for fixed nominal voxel size. The PSF peak amplitude increases as the reciprocal of this product. Theory and experiment demonstrate that acquisition times over 40 sec provide superior resolution compared to shorter acquisitions, despite falling levels of contrast agent concentration. The analysis predicts that an isotropic spatial resolution of 1 mm before zero filling is possible in a FOV large enough to encompass the carotid and vertebral arteries bilaterally. Magn Reson Med 42:1106-1116, 1999.
authors.affiliation: Magnetic Resonance Laboratory, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: S B
authors.initials: SB
authors.lastname: Fain
authors.forename: S J
authors.initials: SJ
authors.lastname: Riederer
authors.forename: M A
authors.initials: MA
authors.lastname: Bernstein
authors.forename: J
authors.initials: J
authors.lastname: Huston
mesh_terms: D002339:Carotid Arteries / Q000033:anatomy & histology; D003287:Contrast Media; D005682:Gadolinium; D006571:Heterocyclic Compounds; D006801:Humans; D007091:Image Processing, Computer-Assisted; D018810:Magnetic Resonance Angiography / Q000379:methods*; D009942:Organometallic Compounds; D019047:Phantoms, Imaging; D013997:Time Factors; D014711:Vertebral Artery / Q000033:anatomy & histology
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium